Japanese contract research and consulting company founded in 2004 by John Winebarger and headquartered in Tokyo, with staff in Japan, Korea and South East Asia, which helped biopharmaceutical companies develop products for Japan and Asia. Provided strategic, medical and scientific consulting on commercial potential and Japanese development plans, regulatory strategy and pathways with the Japanese authorities and full clinical trial management for Japanese and pan Asian studies, and became a wholly owned subsidiary of Chiltern in 2017.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen